Medidas farmacológicas de ahorro de sangre en cirugía

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cirugia Espanola

• Publication date

  2001-02-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S0009-739X(01)71713-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Autologous blood transfusion in patients with hepatocellular carcinoma undergoing hepatectomy.

  2000cited by this paper
• The prospects for red-cell substitutes.

  2000cited by this paper
• Increased safety in the administration of aprotinin: need for a test-dose.

  2000cited by this paper
• The role of preoperative epoetin alfa in men undergoing radical retropubic prostatectomy.

  2000cited by this paper
• Increased safety in the administration of aprotinin: need for a test-dose.

  2000cited by this paper
• Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints

  2000cited by this paper
• Multimodal strategy for reduction of homologous transfusions in cranio-maxillofacial surgery.

  1999cited by this paper
• Erythropoiesis after Therapy with Recombinant Human Erythropoietin: A Dose‐Response Study in Anemic Cancer Surgery Patients

  1999cited by this paper
• Consequences of acute normovolaemic haemodilution on haemostasis during major orthopaedic surgery.

  1999cited by this paper
• A prospective randomized comparison of three blood conservation strategies for radical prostatectomy.

  1999cited by this paper
• Thrombelastogram reveals hypercoagulability after administration of gelatin solution.

  1999cited by this paper
• Recombinant Human Erythropoietin and Hemoglobin Concentration at Operation and during the Postoperative Period: Reduced Need for Blood Transfusions in Patients Undergoing Colorectal Surgery—Prospective Double-blind Placebo-controlled Study

  1999cited by this paper
• Autologous blood donation with recombinant human erythropoietin in anemic patients.

  1999cited by this paper
• Peri‐operative tolerance to large‐dose 6% HES 200/0.5 in major urological procedures compared with 5% human albumin

  1999cited by this paper
• Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion.

  1999cited by this paper
• Comparative study of antifibrinolytic drugs in orthotopic liver transplantation.

  1999cited by this paper
• Current options and approaches for blood management in orthopaedic surgery.

  1999cited by this paper
• Integrated analysis of thrombotic/vascular event occurrence in epoetin alfa-treated patients undergoing major, elective orthopedic surgery.

  1999cited by this paper
• Hemostatic agents and their safety.

  1999cited by this paper
• Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.

  1998cited by this paper
• Immunosuppression induced by homologous blood transfusion

  1998cited by this paper
• Artificial oxygen carriers.

  1998cited by this paper
• Why the Y?

  1998cited by this paper
• Conjugated Estrogen Reduces Transfusion and Coagulation Factor Requirements in Orthotopic Liver Transplantation

  1998cited by this paper
• Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.

  1998cited by this paper
• Aprotinin reduces nitric oxide production in vitro and in vivo in a dose-dependent manner.

  1998cited by this paper
• Oxygen carriers as blood substitutes. Past, present, and future.

  1998cited by this paper
• A second-generation blood substitute (perfluorodichlorooctane emulsion) does not activate complement during an ex vivo circulation model of bypass.

  1998cited by this paper
• Aprotinin versus lysine analogues: the debate continues.

  1998cited by this paper
• Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma.

  1998cited by this paper
• The blood sparing effect of aprotinin should be revisited.

  1998cited by this paper
• Autotransfusion supported by erythropoietin therapy in transurethral resection of the prostate.

  1998cited by this paper
• Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.

  1998cited by this paper
• Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Current Options and Approaches for Blood Management in Orthopaedic Surgery*†

  1998cited by this paper
• The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery

  1998cited by this paper
• In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation.

  1998cited by this paper
• An algorithm to optimize perioperative blood management in surgery.

  1998cited by this paper
• Continuous Small-Dose Tranexamic Acid Reduces Fibrinolysis but not Transfusion Requirements During Orthotopic Liver Transplantation

  1997cited by this paper
• Human haemoglobin from transgenic tobacco

  1997cited by this paper
• Erythropoietin in pediatric cardiac surgery: clinical efficacy and effective dose.

  1997cited by this paper
• Emerging trends in surgical blood transfusion.

  1997cited by this paper
• Desmopressin--a haemostatic drug: state-of-the-art review.

  1997cited by this paper
• Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations.

  1997cited by this paper
• The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: A randomized clinical study

  1997cited by this paper
• Epoetin alfa facilitates presurgical autologous blood donation in non-anaemic patients scheduled for orthopaedic or cardiovascular surgery.

  1997cited by this paper
• Emerging trends in surgical blood transfusion.

  1997cited by this paper
• Clinical potential of intravenously administered perfluorocarbons.

  1997cited by this paper
• Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery.

  1997cited by this paper
• Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red blood cell substitutes.

  1997cited by this paper
• Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery: Meta-Analyses Using Perioperative Blood Transfusion As the Outcome

  1997cited by this paper
• Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation.

  1997cited by this paper
• Tranexamic Acid Radically Decreases Blood Loss and Transfusions Associated with Total Knee Arthroplasty

  1997cited by this paper
• On Augmenting the Relevance and Readability of Anesthesia & Analgesia

  1997cited by this paper
• Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery.

  1996cited by this paper
• Haemodilution induces a hypercoagulable state.

  1996cited by this paper
• Effect of Preoperative Donation of Autologous Blood on Deep-Vein Thrombosis following Total Joint Arthroplasty of the Hip or Knee*

  1996cited by this paper
• Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.

  1996cited by this paper
• Perfluorocarbon Emulsion Prevents Eicoasanoid Release in Skeletal Muscle Ischemia and Reperfusion

  1996cited by this paper
• Blood transfusion in orthopaedic operations.

  1996cited by this paper
• Supporting tissue oxygenation during acute surgical bleeding using a perfluorochemical-based oxygen carrier.

  1996cited by this paper
• Tranexamic Acid Reduces Blood Loss, Transfusion Requirements, and Coagulation Factor Use in Primary Orthotopic Liver Transplantation

  1996cited by this paper
• A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery.

  1996cited by this paper
• Aprotinin in Aortocoronary Bypass Surgery: Increased Risk of Vein-Graft Occlusion and Myocardial Infarction? Supportive Evidence from a Retrospective Study

  1996cited by this paper
• Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid

  1996cited by this paper
• Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid.

  1996cited by this paper
• A Pilot Study of the Effects of a Perflubron Emulsion, AF 0104, on Mixed Venous Oxygen Tension in Anesthetized Surgical Patients

  1996cited by this paper
• The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery.

  1996cited by this paper
• Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery.

  1996cited by this paper
• Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients.

  1996cited by this paper
• Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens.

  1996cited by this paper
• Perfluorocarbons: recent developments and implications for neurosurgery.

  1996cited by this paper
• A hemoglobin-based blood substitute: transplanting a novel allosteric effect of crocodile Hb.

  1996cited by this paper
• Perisurgical erythropoietin application in anemic patients with colorectal cancer: A double-blind randomized study.

  1996cited by this paper
• Perfluorocarbon emulsions and cardiopulmonary bypass: a technique for the future.

  1996cited by this paper
• Use of epoetin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery.

  1996cited by this paper
• Continuous Small-Dose Aprotinin Controls Fibrinolysis During Orthotopic Liver Transplantation

  1996cited by this paper
• The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double‐blind, controlled trial

  1996cited by this paper
• Current Concepts Review - Blood Transfusion in Orthopaedic Operations*

  1996cited by this paper
• The Effects of Recombinant Human Erythropoietin on Perioperative Transfusion Requirements in Patients Having a Major Orthopaedic Operation*

  1996cited by this paper
• Perioperative epoetin alfa reduces transfusion requirements in coronary artery bypass graft surgery. Discussion

  1996cited by this paper
• Haemoglobin-based blood substitutes and sepsis.

  1995cited by this paper
• Oxyradical generation after resuscitation of hemorrhagic shock with blood or stroma-free hemoglobin solution.

  1995cited by this paper
• [Prescribing and performing autologous blood transfusion: experience at a University Medical Center].

  1995cited by this paper
• Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract

  1995cited by this paper
• Effects of 6% Hydroxyethyl Starch and 3% Modified Fluid Gelatin on Intravascular Volume and Coagulation During Intraoperative Hemodilution

  1995cited by this paper
• Detrimental effects of perioperative blood transfusion

  1995cited by this paper
• Aprotinin Decreases Blood Loss in Patients Undergoing Revision or Bilateral Total Hip Arthroplasty

  1995cited by this paper
• Routine intraoperative application of high-dose aprotinin in open heart surgery in adults: antibody formation after first exposure.

  1995cited by this paper
• Allogeneic transfusion risks in the surgical patient.

  1995cited by this paper
• Perfluorocarbons are effective oxygen carriers in cardiopulmonary bypass.

  1995cited by this paper
• Haematocrit, hypertension and risk of stroke.

  1995cited by this paper
• Randomized Study of Aprotinin and DDAVP to Reduce Postoperative Bleeding After Cardiopulmonary Bypass Surgery

  1994cited by this paper
• High‐dose Aprotinin Reduces Blood Loss in Patients Undergoing Total Hip Replacement Surgery

  1994cited by this paper
• Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization.

  1994cited by this paper
• Desmopressin, Surgery and Thrombosis

  1994cited by this paper
• Biomaterial biotechnology using self‐assembled lipid microstructures

  1994cited by this paper
• Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery

  1994cited by this paper
• Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study.

  1994cited by this paper
• [DDAVP: biological effect and clinical utility].

  1994cited by this paper
• Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation

  1994cited by this paper

• Capítulo 41 – Testigos de Jehová

  2010cites this paper
• Eficacia del ácido épsilon amino caproico en la reducción de sangrado posoperatorio en cirugía cardiaca

  2010cites this paper
• Factores predictivos de la necesidad de transfusión en la fractura subcapital de cadera en pacientes mayores de 65 años

  2003cites this paper
• Guas para la reposicin de las prdidas sanguneas en ciruga abdominal de urgencia

  2003cites this paper
• Transfusión sanguínea perioperatoria en el paciente neoplásico. I. Alteraciones inmunológicas y consecuencias clínicas

  2002cites this paper
• Transfusión sanguínea perioperatoria en el paciente neoplásico (II). Alternativas para la reducción de los riesgos transfusionales

  2002cites this paper
• La hemoglobina preoperatoria como único factor predictor de las necesidades transfusionales en la artroplastia de rodilla

  2002cites this paper